USP <797> also introduces a new definition of what constitutes compounding. In the case of a bag-and-vial system, in which a medication vial is attached, with adaptor, to the bag that it needs to be mixed in for infusion, if a nurse attaches the bag and vial, that is not rega...
4.Storage: USP <797> placed HDs in a separate space to prevent contamination and personal exposure. However, USP <800> takes the 2014 National Institute for Occupational Safety and Health (NIOSH) HD stratification into consideration, stating that nonantineoplastic HDs, reproductive risk—only HDs, ...
Resources to learn more about USP <825>: On-demand USP <825> webinars Visit the USP website Subscribe to receive USP <825> updates Quality and Compliance For more information about USP <825>, please reach out toyour local nuclear pharmacy. ...
虽然国内外研究者围绕肿瘤细胞对EGFR-TKI的耐药机制做了大量的工作,发现了肿瘤细胞携带EGFR突变(EGFR T790M、EGFR C797X等)、PTEN突变、mTOR突变以及 PIK3CA突变等是EGFR-TKI耐药的标志物[1],但仍有 20-30%患者耐药机制尚未明确【2】...
chapter is not specific about whether to don these covers before entering the C-SEC. The intent is to “provide protection from contact with HD residue.” Two pairs of shoe covers must be worn when compounding HDs. The second pair must be donned before entering the C-SEC. Shoe covers must...